Publications

McCann, L.J., Arnold, K., Pilkington, C.A., Huber, A.M., Ravelli, A., Beard, L., Beresford, M.W., Wedderburn, L.R. (2014)
Developing a provisional, international Minimal Dataset for Juvenile Dermatomyositis: for use in clinical practice to inform research
Tansley, S., Betteridge, Z.E., Gunawardena, H., Jacques, T.S., Owens, C., Pilkington, C., Arnold, K., Yasin, S., Moraitis, E., Wedderburn, L.R., McHugh, N.J., on behalf of JDRG (2014)
Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study.
Jani, M., Massey, J., Wedderburn, L.R., Vencovsky, J., Danko, K., Lundberg, I., Padyukov, L., Selva O’Callaghan, A., Radstake, T., Platt, H., Warren, R.B., Griffiths, C.E., Lee, A., Gregerson P.K., Miller, F.W., Ollier, W.E., Cooper, R.G., Chinoy, H., Lamb, J.A. and EUMYONET. (2014).
Genotyping of immune-related genetic variants identifies TYK2 as a novel risk locus for idiopathic inflammatory myopathies.
Tansley, S.L, Betteridge, Z.E., Shaddick, G., Gunawardena, H., Arnold, K., Wedderburn, L. R. and McHugh, N.J. on behalf of EUMyoNet and JDRG. (2014).
Calcinosis in Juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset.
Miller, F.W., Cooper, R.G., Vencovský, J., Rider, L.G., Danko, K., Wedderburn, L.R., Lundberg, I.E., Pachman, L.M., Reed, A.M., Ytterberg, S.R., Padyukov, L., Selva-O'Callaghan, A., Radstake, T.R., Isenberg, D.A., Chinoy, H., Ollier, W.E., O'Hanlon, T.P., Peng, B., Lee. A., Lamb, J.A., Chen. W., Amos, C.I., Gregersen, P.K; Myositis Genetics Consortium (2013)
Genome-wide association study of dermatomyositis reveals genetic overlap with other autoimmune disorders.
Varsani, H., Charman S. C. Li, C.K., Marie, S., Amato, A.A. Banwell, B., Bove, K.E., Corse, A.M., Emslie-Smith, A., Jacques, T.S., Lundberg, I.E., Minetti, C., Nenesmo, I., Rushing, E.J., Sallum, A.M., Sewry, C., Pilkington, C.A., Holton, J.A., Wedderburn L.R and the UK JDRG. (2013)
Validation of a score tool for measurement of pathological severity in juvenile dermatomyositis and correlation with clinical severity of disease.
Nistala, K., Varsani,H., Wittkowski, H., Volg, T., Krol P., Shah, V., Mamchaoui K. Brogan, P., Roth, J., and Wedderburn, L. R. (2013)
Myeloid related proteins induce muscle derived inflammatory mediators in Juvenile Dermatomyositis.
Lazarevic D, Pistorio A, Palmisani E, Miettunen P, Ravelli A, Pilkington C, Wulffraat NM, Malattia C, Garay SM, Hofer M, Quartier P, Dolezalova P, Penades IC, Ferriani VP, Ganser G, Kasapcopur O, Melo-Gomes JA, Reed AM, Wierzbowska M, Rider LG, Martini A, Ruperto N; for the Paediatric Rheumatology International Trials Organisation (PRINTO) (2013).
The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis.
}))